OmniAb Inc.
Organization details
- Legal name
- OmniAb Inc.
- Former names
- Avista Public Acquisition Corp. II
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8731 — Services-Commercial Physical & Biological Research
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Emeryville
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OABI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001846253
Board of directors
-
Carolyn R. Bertozzi · DirectorSince 2023
-
David F. Burgstahler · DirectorSince 2023
-
Jennifer R. Cochran · DirectorSince 2023
-
John L. Higgins · DirectorSince 2023
-
Joshua Alexander Tamaroff · DirectorSince 2023
-
Matthew W. Foehr · Director · President and CEOSince 2023
-
Philip J. Gotwals · DirectorSince 2025
-
Sarah Boyce · DirectorSince 2023
-
Steven C. Crouse · DirectorSince 2025
-
Steven Love · DirectorSince 2023
-
Sunil Patel · DirectorSince 2023
-
Thompson Dean · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
69.0%
-
98.0%
Board connections
5 of this board's directors also sit on 7 other boards. 7 are in the same sector.
-
Alnylam Pharmaceuticals Inc. Same sectorvia Carolyn R. Bertozzi
-
Atrium Therapeutics Inc. Same sectorvia Sarah Boyce
-
Bio-Techne Corp Same sectorvia John L. Higgins
-
Capricor Therapeutics Inc. Same sectorvia Philip J. Gotwals
-
Contineum Therapeutics Inc. Same sectorvia Sarah Boyce
-
Eli Lilly and Company Same sectorvia Carolyn R. Bertozzi
-
Viking Therapeutics Inc. Same sectorvia Matthew W. Foehr
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $283,036
- 12 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 1, 2026 | Steven Love Director | Option exercise | +13,334 | — | — |
| Jun 17, 2026 | Carolyn R. Bertozzi Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | Jennifer R. Cochran Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | Steven C. Crouse Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | Philip J. Gotwals Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | John L. Higgins Director | Option exercise | +20,000 | — | — |
| Jun 17, 2026 | Steven Love Director | Option exercise | +20,000 | — | — |
| Apr 21, 2026 | Philip J. Gotwals Director | Option exercise | +13,333 | — | — |
| Apr 21, 2026 | Steven C. Crouse Director | Option exercise | +13,333 | — | — |
| Apr 7, 2026 | Matthew W. Foehr Director, Officer (President and CEO) | Option exercise | +36,459 | — | — |
| Apr 7, 2026 | Kurt A. Gustafson Officer (Executive VP, Finance and CFO) | Option exercise | +13,542 | — | — |
| Apr 7, 2026 | Berkman Charles S Officer (Chief Legal Officer) | Option exercise | +13,542 | — | — |
| Apr 7, 2026 | Matthew W. Foehr Director, Officer (President and CEO) | Open-market sale | −19,244 | $1.49 | $28,674 |
| Apr 7, 2026 | Kurt A. Gustafson Officer (Executive VP, Finance and CFO) | Open-market sale | −6,913 | $1.49 | $10,300 |
| Apr 7, 2026 | Berkman Charles S Officer (Chief Legal Officer) | Open-market sale | −7,157 | $1.49 | $10,664 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about OmniAb Inc.
Who is the CEO of OmniAb Inc.?
Matthew W. Foehr is OmniAb Inc.'s President & CEO.
How many directors are on OmniAb Inc.'s board?
OmniAb Inc.'s board has 12 directors: Carolyn R. Bertozzi, David F. Burgstahler, Jennifer R. Cochran, John L. Higgins, Joshua Alexander Tamaroff, Matthew W. Foehr, Philip J. Gotwals, Sarah Boyce, Steven C. Crouse, Steven Love and 2 others.
Are OmniAb Inc. insiders buying or selling shares?
Over the last 12 months, OmniAb Inc. insiders made no open-market purchases and sold $283,036 of shares in 12 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="omniab-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.